Nuo Therapeutics, Inc. (AURX)
OTCMKTS
· Delayed Price · Currency is USD
1.400
-0.050 (-3.45%)
Jul 11, 2025, 4:00 PM EDT
Nuo Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 0.06 | 0.28 | 0.93 | 2.05 | 1.41 | 0.16 | Upgrade
|
Cash & Short-Term Investments | 0.06 | 0.28 | 0.93 | 2.05 | 1.41 | 0.16 | Upgrade
|
Cash Growth | -84.80% | -69.45% | -54.73% | 45.01% | 776.26% | -32.81% | Upgrade
|
Accounts Receivable | 0.28 | 0.25 | 0.25 | 0.09 | - | - | Upgrade
|
Receivables | 0.28 | 0.25 | 0.25 | 0.09 | - | - | Upgrade
|
Inventory | 0.1 | 0.15 | 0.21 | 0.24 | - | - | Upgrade
|
Prepaid Expenses | 0.17 | 0.16 | 0.17 | 0.2 | 0.05 | - | Upgrade
|
Restricted Cash | - | - | - | 0.06 | - | - | Upgrade
|
Total Current Assets | 0.6 | 0.84 | 1.56 | 2.63 | 1.47 | 0.16 | Upgrade
|
Property, Plant & Equipment | 0.55 | 0.35 | 0.31 | 0.41 | - | - | Upgrade
|
Total Assets | 1.15 | 1.19 | 1.88 | 3.05 | 1.47 | 0.16 | Upgrade
|
Accounts Payable | 0.66 | 0.22 | 0.39 | 0.4 | 0.53 | 0.52 | Upgrade
|
Accrued Expenses | 0.35 | 0.29 | 0.19 | 0.12 | 0.15 | 0.15 | Upgrade
|
Current Portion of Leases | 0.07 | 0.07 | 0.09 | 0.08 | - | - | Upgrade
|
Current Unearned Revenue | 0.2 | - | - | - | - | - | Upgrade
|
Total Current Liabilities | 1.28 | 0.58 | 0.67 | 0.6 | 0.67 | 0.66 | Upgrade
|
Long-Term Leases | 0.08 | 0.1 | 0.16 | 0.26 | - | - | Upgrade
|
Other Long-Term Liabilities | - | - | - | -0 | - | - | Upgrade
|
Total Liabilities | 1.36 | 0.68 | 0.84 | 0.86 | 0.67 | 0.66 | Upgrade
|
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Additional Paid-In Capital | 32.79 | 32.77 | 30.97 | 28.95 | 24.38 | 23 | Upgrade
|
Retained Earnings | -33.01 | -32.26 | -29.94 | -26.76 | -23.59 | -23.5 | Upgrade
|
Total Common Equity | -0.21 | 0.51 | 1.04 | 2.19 | 0.79 | -0.5 | Upgrade
|
Shareholders' Equity | -0.21 | 0.51 | 1.04 | 2.19 | 0.79 | -0.5 | Upgrade
|
Total Liabilities & Equity | 1.15 | 1.19 | 1.88 | 3.05 | 1.47 | 0.16 | Upgrade
|
Total Debt | 0.15 | 0.16 | 0.26 | 0.34 | - | - | Upgrade
|
Net Cash (Debt) | -0.09 | 0.12 | 0.67 | 1.72 | 1.41 | 0.16 | Upgrade
|
Net Cash Growth | - | -82.25% | -60.78% | 21.32% | 776.26% | - | Upgrade
|
Net Cash Per Share | -0.00 | 0.00 | 0.02 | 0.04 | 0.05 | 0.01 | Upgrade
|
Filing Date Shares Outstanding | 46.82 | 46.82 | 44.24 | 41.8 | 37.12 | 25.69 | Upgrade
|
Total Common Shares Outstanding | 46.82 | 46.82 | 44.24 | 41.8 | 37.12 | 25.69 | Upgrade
|
Working Capital | -0.68 | 0.26 | 0.89 | 2.03 | 0.79 | -0.5 | Upgrade
|
Book Value Per Share | -0.00 | 0.01 | 0.02 | 0.05 | 0.02 | -0.02 | Upgrade
|
Tangible Book Value | -0.21 | 0.51 | 1.04 | 2.19 | 0.79 | -0.5 | Upgrade
|
Tangible Book Value Per Share | -0.00 | 0.01 | 0.02 | 0.05 | 0.02 | -0.02 | Upgrade
|
Machinery | 0.84 | 0.61 | 0.45 | 0.45 | 0.39 | - | Upgrade
|
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.